Brian Henry News
-
Express Scripts Inc. persuaded a judge to dismiss most of the legal claims filed by groups of retail drug stores challenging its $29.1 billion acquisition of Medco Health Solutions Inc.
-
U.S. banks with more than $10 billion in assets may get more time to institute internal stress testing required by the Dodd-Frank Act, U.S. banking regulators said yesterday.
-
Five states are considering whether they will sue to challenge Express Scripts Inc.’s bid for Medco Health Solutions Inc. if federal antitrust regulators approve the deal, two people familiar with the matter said.
-
Medtronic Inc. , the world’s largest medical device maker, said it received a warning letter from U.S. regulators about reporting requirements and handling of complaints at its Louisville, Colorado, plant.
-
Suffering from an aching back, truck driver Mikel Hehn went to see surgeon Jeffrey Gerdes in 2008. The St. Cloud, Minnesota, doctor diagnosed spinal disc degeneration, commonly treated with physical therapy, and said surgery wasn’t called for.
-
Express Scripts Inc.’s bid for Medco Health Solutions Inc. should be approved by U.S. antitrust regulators only if the combined company allows customers to buy specialty drugs at pharmacies that compete with their own, a lawyer for independent rivals said.
-
Walgreen Co. and Express Scripts Inc. agreed to dismiss all claims in a contract dispute that started last year and was sent to arbitration.
-
Walgreen Co. is willing to resume selling prescriptions to Express Scripts Inc. customers after the end of their contract Dec. 31 forced millions of consumers to switch pharmacies, Walgreen’s pharmacy-services chief said.
-
China’s decision to allow Citigroup Inc. to issue credit cards in its own name may signal a step toward the government in Beijing opening its banking industry.
-
Medco Health Solutions Inc. fell the most in almost six months after Reuters reported that “key people” at the U.S. Federal Trade Commission are seeking to stop the company’s proposed $29.1 billion acquisition by rival pharmacy benefits company Express Scripts Inc.
|
|
Most Popular on Bloomberg
|
| |